A randomized phase I trial of melphalan + bortezomib as conditioning for autologous transplant for myeloma
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Emory University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2290765521
